Literature DB >> 1349164

p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells.

S R Rittling1, D T Denhardt.   

Abstract

We have asked whether p53 mutations are involved in the process of spontaneous immortalization of mouse embryo cells. Cells from Swiss mouse embryos were used to prepare 3T3 and 3T12 lines according to the protocol of Todaro & Green [(1963). J. Cell Biol., 17, 299-313]. After the cells emerged from crisis, p53 sequences were amplified by polymerase chain reaction (PCR) from both RNA and DNA. The sequence of the aggregated cDNA from each of six 3T3 lines showed no evidence of mutation. PCR-amplified p53 cDNA from two 3T3 lines was cloned, and individual clones in M13mp19 were partially sequenced. One cell ine showed a single, non-coding nucleotide change in 2/8 independent clones. Nine cDNA clones from the second 3T3 lines were sequenced, and no single nucleotide changes appeared more than once. The mutations which appeared only once were not detected in clones of genomic DNA. Since these apparent mutations are probably reverse transcriptase or Taq polymerase errors, we conclude that both the 3T3 lines contained only wild-type p53. In two out of three independent 3T12 lines however, missense mutations were readily observed in the aggregate cDNA sequence. Restriction fragment length polymorphism and Southern blot analyses of the genomic DNA indicated that these cells were homozygous for the mutations. The p53 protein molecules in four cell lines were analysed by immunoprecipitation: one 3T12 line showed the pattern of antibody reactivity characteristic of some p53 mutants, while the others displayed the wild-type pattern. We conclude that p53 mutations arise and are strongly selected for during immortalization according to the 3T12 but not the 3T3 protocol.

Entities:  

Mesh:

Year:  1992        PMID: 1349164

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation.

Authors:  Kader Yagiz; Susan R Rittling
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

3.  Characterization of the p53-dependent postmitotic checkpoint following spindle disruption.

Authors:  J S Lanni; T Jacks
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

4.  A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drug.

Authors:  Carmela Fimognari; Luca Sangiorgi; Silvia Capponcelli; Michael Nüsse; Silvia Fontanesi; Fausto Berti; Silvia Soddu; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Invest New Drugs       Date:  2005-06       Impact factor: 3.850

5.  Wild-type and Hupki (human p53 knock-in) murine embryonic fibroblasts: p53/ARF pathway disruption in spontaneous escape from senescence.

Authors:  Catherine Whibley; Adam F Odell; Tatiana Nedelko; Gregor Balaburski; Maureen Murphy; Zhipei Liu; Louisa Stevens; John H Walker; Michael Routledge; Monica Hollstein
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

6.  Different telomere damage signaling pathways in human and mouse cells.

Authors:  Agata Smogorzewska; Titia de Lange
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

7.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication.

Authors:  J Craig Forrest; Clinton R Paden; Robert D Allen; Julie Collins; Samuel H Speck
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

9.  Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism.

Authors:  J W Peacock; S Benchimol
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

10.  SIRT2 is required for efficient reprogramming of mouse embryonic fibroblasts toward pluripotency.

Authors:  Ah-Young Kim; Eun-Mi Lee; Eun-Joo Lee; Jae-Hong Kim; Kyoungho Suk; Eunhye Lee; Keun Hur; Yean Ju Hong; Jeong Tae Do; SunYoung Park; Kyu-Shik Jeong
Journal:  Cell Death Dis       Date:  2018-08-30       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.